Skip to main content
Signal8
Chagin Karen Deborah profile photo

Karen Deborah Chagin

CIK: 0002070710

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Context Therapeutics Inc. logo
CNTX

Context Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Context Therapeutics Inc. logo
    CNTX

    Context Therapeutics Inc.

    Feb 19, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    290K shares-
  • Context Therapeutics Inc. logo
    CNTX

    Context Therapeutics Inc.

    Jun 9, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    153K shares-

1-2 of 2

About Chagin Karen Deborah

Chagin Karen Deborah (SEC CIK 0002070710) files insider reports with the SEC as Chief Medical Officer of Context Therapeutics Inc. (CNTX).

Signal8 holds 3 ownership filings by Chagin Karen Deborah (1 Form 3, 2 Form 4), filed between Jun 9, 2025 and Feb 23, 2026. Those filings report 2 transactions, from Jun 9, 2025 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chagin Karen Deborah's filings is in PHILADELPHIA, PA.

Recent filings by Chagin Karen Deborah

  • Feb 19, 2026: Grant or award of CNTX derivative securities (Form 4, code A).
  • Jun 9, 2025: Grant or award of CNTX derivative securities (Form 4, code A).

Other insiders filing for Context Therapeutics Inc. (CNTX)

How to read Form 4 transaction codes